Application of a new biological pathogenetic therapy of migraine in clinical practice: expert consensus of the Russian Headache Research Society

Application of a new biological pathogenetic therapy of migraine in clinical practice: expert consensus of the Russian Headache Research Society

This consensus reviewed the main current issues of clinical application and integration into everyday practice of a new targeted preventive therapy for migraine using monoclonal antibodies (mAbs) to the calcitonin gene related peptide (CGRP) ligand or receptor. These recommendations are based on cur...

Full description

Bibliographic Details
Main Authors: A. V. Sergeev, G. R. Tabeeva, E. G. Filatova, A. V. Amelin, L. R. Akhmadeeva, E. R. Lebedeva, V. V. Osipova, Yu. E. Azimova, N. V. Latysheva, O. B. Doronina, K. V. Skorobogatykh
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2022-10-01
Series:Неврология, нейропсихиатрия, психосоматика
Subjects:
migraine
monoclonal antibodies
calcitonin gene-related peptide
consensus
Online Access:https://nnp.ima-press.net/nnp/article/view/1900

Internet

https://nnp.ima-press.net/nnp/article/view/1900

Similar Items